-Frontline A Delhi High Court verdict says the State government is bound to ensure that poor and vulnerable sections of society have access to treatment for rare and chronic diseases. SEVEN-YEAR-OLD Mohammed Ahmed Khan looked on helplessly as his father, Sirajuddin, narrated the sordid tale of the loss of four of his children to Gaucher's disease, a rare genetic disease that requires lifelong, exorbitantly expensive enzyme replacement therapy. Sirajuddin, a rickshaw...
More »SEARCH RESULT
Total Matching Records found : 257
Activists demand access to affordable oral hepatitis drugs
-Down to Earth Giving patents to foreign-made medicines will add to patients' woes, they urge Health activists staged a protest in front of the office of Union Ministry of Health and Family Welfare on Friday, demanding that the government should ensure that oral drugs to treat Hepatitis C are made available to patients. The demonstrators were later assured by the ministry officials that they would look into the matter...
More »Smuggled Medicines Save Lives -Ashfaq Yusufzai
-IPS News PESHAWAR, Pakistan- They are contraband, yet a large number of Pakistanis have come to depend on drugs made in India and smuggled into Pakistan. Patients as well as doctors say these are cheap and effective, even as law enforcers look the other way. The two countries do not have a trade agreement on drugs, but markets in Khyber Pakhtunkhwa province in the north of Pakistan do brisk business in India-made...
More »Steps to improve Healthcare in Rural India
-Press Information Bureau (Ministry of Health and Family Welfare) Healthcare for all, particularly for the rural areas has been a priority for the Government. The health indicators like Infant Mortality Rate (IMR), Total Fertility Rate (TFR), and nutritional status of children under 3 years including prevalence of anemia amongst them and pregnant women in rural area are considerably poor as compared to urban areas. The key health indicators are as under: Public...
More »India patent regime not about access to medicine: U.S body
-The Hindu Chennai: With U.S Trade Representative Michael Froman set to announce a trade enforcement action tied to India, the highly influential U.S Chamber of Commerce has lashed out at India's recent pattern of pharma patent denials, pointing out that the country's actions "are not about access to medicine." In the case of Swiss drug-maker Novartis, whose cancer drug's patent protections were dismissed by the Supreme Court, the chamber has argued that...
More »
